These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 7387200)

  • 1. [Comparative study of the fibrinolytic system in different species (author's transl)].
    Badimón L; Villaverde CA; Vidal M; Badimón JJ; Valdecasas FG
    Arch Farmacol Toxicol; 1980 Apr; 6(1):17-26. PubMed ID: 7387200
    [No Abstract]   [Full Text] [Related]  

  • 2. A comparative study of the inhibitors of fibrinolysis in human, dog and rabbit blood.
    Gallimore MJ; Nulkar MV; Shaw JT
    Thromb Diath Haemorrh; 1965 Sep; 14(1-2):145-58. PubMed ID: 16955972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Synthetic compounds with fibrinolytic and thrombolytic activity. I. Pharmacologic observations].
    Desnoyers P
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1976; 103(3):351-6. PubMed ID: 63421
    [No Abstract]   [Full Text] [Related]  

  • 4. Activity of coagulation and fibrinolysis parameters in animals.
    Karges HE; Funk KA; Ronneberger H
    Arzneimittelforschung; 1994 Jun; 44(6):793-7. PubMed ID: 8053983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Fibrinogen level and fibrinolytic activity of plasma euglobulins from rabbits infected with different types of Salmonella (author's transl)].
    Prokopowicz D; Jarocki F
    Zentralbl Bakteriol Orig A; 1977 Sep; 239(1):51-8. PubMed ID: 339609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of a recombinant chimeric plasminogen activator composed of Gly-Pro-Arg-Pro tetrapeptide and truncated urokinase-type plasminogen activator expressed in Escherichia coli.
    Hua ZC; Chen XC; Dong C; Zhu DX
    Biochem Biophys Res Commun; 1996 May; 222(2):576-83. PubMed ID: 8670247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Serial changes in hemostatic and fibrinolytic states induced by coronary thrombolytic therapy].
    Goto S; Handa S; Abe S; Takahashi E; Kawai Y; Watanabe K; Yoshikawa T; Hori S; Ikeda Y
    J Cardiol; 1993; 23(4):335-41. PubMed ID: 8064582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Studies on unexplained renal hematuria. 1. Clinical studies of peripheral blood examination and fibrinolytic enzyme systems in patients with various types of renal hematuria (author's transl)].
    Hayashi M
    Nihon Hinyokika Gakkai Zasshi; 1981 Jan; 72(1):42-59. PubMed ID: 7024604
    [No Abstract]   [Full Text] [Related]  

  • 9. Fibrinolytic activity in blood is distributed over a cellular and the plasma fraction which can be modulated separately.
    van Giezen JJ; Chung-A-Hing JE; Vegter CB; Bouma BN; Jansen JW
    Thromb Haemost; 1994 Dec; 72(6):887-92. PubMed ID: 7740459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Combined thrombolysis by pharmacokinetically different plasminogen activators].
    Maksimenko AV
    Bioorg Khim; 1998 May; 24(5):376-80. PubMed ID: 9661792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kidney tissue activator of fibrinolysis in relation to pregnancy.
    Epstein MD; Beller FK; Douglas GW
    Obstet Gynecol; 1968 Oct; 32(4):494-504. PubMed ID: 4193253
    [No Abstract]   [Full Text] [Related]  

  • 12. Relationship of urokinase type plasminogen activator, plasminogen activator inhibitor type 1 and activated protein C in fibrinolysis of human placenta.
    Moniwa N
    Pol J Pharmacol; 1996; 48(2):215-20. PubMed ID: 9112654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The plasminogen content of a commercially available bovine fibrinogen (author's transl)].
    Auel H; Martin M
    Z Klin Chem Klin Biochem; 1974 Aug; 12(8):385-8. PubMed ID: 4428851
    [No Abstract]   [Full Text] [Related]  

  • 14. [Role of urokinase in regulating the fibrinolytic activity of blood in normal dogs].
    Kuznik VI; Vasilev DV
    Patol Fiziol Eksp Ter; 1981; (3):45-7. PubMed ID: 7024896
    [No Abstract]   [Full Text] [Related]  

  • 15. Plasminogen activators and inhibitor type-1 in alveolar osteitis.
    Serratì S; Margheri F; Bruschi S; D'Alessio S; Pucci M; Fibbi G; Tonelli P; Del Rosso M
    Eur J Oral Sci; 2006 Dec; 114(6):500-3. PubMed ID: 17184232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of Borrelia burgdorferi-bound fibrinolytic enzymes by alpha2-antiplasmin, PAI-1 and PAI-2.
    Perides G; Noring R; Klempner MS
    Biochem Biophys Res Commun; 1996 Feb; 219(3):690-5. PubMed ID: 8645243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood urokinase plasminogen activator system in chronic urticaria.
    Kasperska-Zajac A; Brzoza Z; Rogala B
    Arch Dermatol Res; 2007 Jan; 298(8):409-11. PubMed ID: 17102952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Activation system of fibrinolysis (author's transl)].
    Okamoto U
    Rinsho Ketsueki; 1974 Aug; 15(8):827-39. PubMed ID: 4613880
    [No Abstract]   [Full Text] [Related]  

  • 19. Growth factor-dependent proliferation and invasion of muscle satellite cells require the cell-associated fibrinolytic system.
    Fibbi G; D'Alessio S; Pucci M; Cerletti M; Del Rosso M
    Biol Chem; 2002 Jan; 383(1):127-36. PubMed ID: 11928807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular cell-derived fibrinolytic regulators and atherothrombotic vascular disorders (Review).
    Shen GX
    Int J Mol Med; 1998 Feb; 1(2):399-408. PubMed ID: 9852242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.